Stay updated with breaking news from Performance First Quarter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
May 2, 2024 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2024 Highlights The U.S. Food and Drug Administration granted Priority Review for the supplemental Biologics...
Genmab Announces Financial Results for the First Quarter of 2024 May 2, 2024 Copenhagen, Denmark; Interim Report for the First Quarter Ended...
Faced with global developments, BRI focuses on domestic challenges.
May 10, 2023 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2023 Highlights Genmab revenue increased 35% compared to the first quarter of 2022, to DKK 2,854 million ... | May 10, 2023
Genmab Announces Financial Results for the First Quarter of 2022May 11, 2022 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2022HighlightsDARZALEX® net sales as reported by Johnson & Johnson increased 36% compared to the first three months of 2021 to USD 1,856 million, resulting in...